SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (151)12/2/1998 10:58:00 AM
From: Arthur Radley  Read Replies (1) | Respond to of 1475
 
Morning Rich,
I have a small position in CTRX. It has had a heck of a run over the past few days. Up another 10% this morning. What is your take on this biotech? Thanks in advance.



To: scaram(o)uche who wrote (151)12/6/1998 2:28:00 PM
From: scaram(o)uche  Respond to of 1475
 
from 11/1 issue of JI.....

Uncoupling Activation-Dependent HS1 Phosphorylation from Nuclear Factor of
Activated T Cells Transcriptional Activation in Jurkat T Cells: Differential
Signaling Through CD3 and the Costimulatory Receptors CD2 and CD281
Jill E. Hutchcroft,2* Jacqueline M. Slavik,* Huamao Lin,* Takeshi Watanabe,† and Barbara E. Bierer3*‡
*Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; †Department of Molecular Immunology,
Kyushu University, Fukuoka, Japan; and ‡Department of Pediatrics and Medicine, Harvard Medical School, Boston, MA 02115
The Journal of Immunology, 1998, 161: 4506-4512.

CD3, CD2, and CD28 are functionally distinct receptors on T lymphocytes. Engagement of any of these receptors induces the rapid
tyrosine phosphorylation of a shared group of intracellular signaling proteins, including Vav, Cbl, p85 phosphoinositide 3-kinase, and
the Src family kinases Lck and Fyn. Ligation of CD3 also induces the tyrosine phosphorylation of HS1, a 75-kDa hematopoietic
cell-specific intracellular signaling protein of unknown function. We have examined changes in HS1 phosphorylation after
differential stimulation of CD3, CD2, and CD28 to elucidate its role in T cells and to further delineate the signaling pathways
recruited by these receptors. Unlike ligation of CD3, stimulation with anti-CD28 mAb or CHO cells expressing the CD28 ligands
CD80 or CD86 did not lead to tyrosine phosphorylation of HS1 in Jurkat T cells. Additionally, no tyrosine phosphorylation of HS1
was induced by mitogenic pairs of anti-CD2 mAbs capable of activating the transcription factor NFAT (nuclear factor of activated
T cells). Costimulation through CD28 and/or CD2 did not modulate the CD3-dependent phosphorylation of HS1. In vivo studies
indicated that CD3-induced HS1 phosphorylation was dependent upon both the Src family tyrosine kinase Lck and the tyrosine
phosphatase CD45, did not require MEK1 kinase activity, and was regulated by protein kinase C activation. Thus, although CD3,
CD28, and CD2 activate many of the same signaling molecules, they differed in their capacity to induce the tyrosine phosphorylation
of HS1. Furthermore, activation-dependent tyrosine phosphorylation of HS1 was not required for NFAT transcriptional activation.